# Director, KAT6i (Prifetrastat) Launch Lead, US Breast Cancer — Pfizer

- Location: United States
- Posted pay: $177k–$294k/yr
- Posted: Nov 16, 2026
- Status: open (checked Nov 21, 2026)
- Apply (employer's site): https://pfizer.wd1.myworkdayjobs.com/PfizerCareers/job/United-States---New-York---New-York-City/Director--KAT6i--Prifetrastat--Launch-Lead--US-Breast-Cancer_4968033-1
- Employer record: https://visajobs.io/company/pfizer.md

## Sponsorship history
- Tier: Employer history only
- With this exact title: 0

## Description
ROLE SUMMARY
Pfizer Commercial Oncology is introducing the world to the next era of cancer care. With a growing portfolio of novel therapies, industry-leading R&D, and a goal of delivering eight breakthroughs by 2030 across major cancer types, we're translating cutting-edge science into market-shaping impact. Here, you'll partner with exceptional colleagues across scientific, medical, and manufacturing teams, backed by advanced digital and AI-enabled infrastructure and the authority to accelerate medicines from discovery to delivery. Guided by our values of courage, excellence, equity, and joy, you'll have the opportunity to stretch your skills and build a career that evolves with you—across teams, roles, and the Pfizer enterprise. Join us to make history — for patients, for their families, for the future.
Prifetrastat is Pfizer’s first-in-class oral KAT6 inhibitor, in development with fulvestrant for adults with previously treated HR+/HER2- metastatic breast cancer (BC). Prifetrastat is the next wave of Pfizer’s breast cancer portfolio and a chance to launch a new mechanism of action in a crowded post-CDK4/6 inhibitor landscape.
This role leads US launch readiness for prifetrastat. You will own one integrated launch plan across the brand team, market development, access, and operations, and drive the cross-functional team to every milestone from pre-launch through approval and first patient. You will work in step with the Global Launch Team so the US plan reflects global strategy and US realities, and you will collaborate closely with Commercial, Medical, Legal, Regulatory, Market Access, Supply, Sales, and Global. This role reports to the US IBRANCE / BC Pipeline Brand Lead. The BC team is a large, dynamic team with significant opportunity, so responsibilities may shift over time based on business needs and individual interest.
This is a role for a marketing leader who thrives on solving complex problems in a competitive market. This individual must be able to excel in a fast-paced, matrixed environment, make immediate business impact, think outside the box, and actively contribute to a positive team culture. The leader in this role will define how prifetrastat reaches customers at launch, including how field, omnichannel, and digital engagement work together and which capabilities the team needs to build ahead of approval. The ideal candidate is a marketing or launch leader who thrives in ambiguity, influences without authority in a large matrix, and delivers on a long runway with a clear plan.
ROLE RESPONSIBILITIES
Integrated launch plan: Lead the US cross-functional launch team and own the integrated launch plan from pre-launch through approval and first patient
Set the milestones, ways of working, and meeting cadence, and deliver stage-gate and governance requirements on time
Surface cross-functional interdependencies early, and escalate and resolve issues that put readiness at risk before they affect the timeline.
Strategy into action: Turn the brand strategy and OGSM into owned, dated workstreams that address the launch-critical issues: differentiation in a fragmented post-CDK4/6 landscape, biomarker testing readiness, tolerability and dose-management support for clinicians and patients, and customer value
Give each issue a clear owner, a deliverable, and a link to the evidence, insights, and market research that inform it, so strategy shows up in execution
Market development: Plan and sequence unbranded market development within pre-approval guardrails, including a shared HR+/HER2- platform with other Pfizer breast cancer assets
Partner with Legal, Regulatory, Medical, and Compliance to keep activity compliant, and coordinate market research, advisory boards, KOL engagement, and congress plans so insights reach the launch plan in time to shape decisions
Operational readiness: Partner with Supply, Regulatory, and Market Access to land US readiness decisions on time, including pack configuration, artwork, and channel set-up
Bring commercial input to decisions that carry pricing and access consequences, such as dose strengths and pack format, and take them to governance early enough to act
Track supply-side milestones against the US plan so commercial and supply timelines stay aligned.
Scenarios and risk: Maintain launch scenarios for approval timing, standard-of-care shifts, and competitor entry, each with an owner and a decision date
Pressure-test launch assumptions as data and the landscape evolve, set triggers for when plans need to change, and keep mitigations ready so the team can move quickly if the timeline accelerates or the market shifts
Launch health and alignment: Build the launch KPI dashboard, report readiness to senior leadership on a regular cadence, and align with the Global Launch Team and the atirmociclib and IBRANCE teams on narrative, investment, and customer engagement so the breast cancer portfolio speaks with one voice
Lead resource planning through the OP (operating plan) process, including how the team and budget ramp as launch approaches
Building innovation without a playbook: Build new approaches from the ground up where no established playbook exists, with a particular focus on AI and the go-to-market model
Identify and pilot practical uses of AI across launch planning and execution, such as insight synthesis, scenario modeling, and content development, working with Digital, Data Science, Legal, and Compliance so tools are used responsibly
BASIC QUALIFICATIONS
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including the ability to influence and collaborate with peers, achieve meaningful outcomes, and create business impact.
BA/BS required; 8+ years of pharmaceutical, biotech, or healthcare commercial experience, including launch management, integrated marketing operations, and cross-functional project leadership; Masters with 7+ years
Ability to run multiple concurrent workstreams, stakeholders, and deadlines with hi

> History, not a promise: past H-1B filings do not mean an employer will sponsor you or a given role. Data: U.S. DOL OFLC LCA disclosure (FY2024–FY2026 for role counts, certified LCAs) and the USCIS H-1B Employer Data Hub. Not legal advice. Methodology: https://visajobs.io/methodology
